vs
NACCO INDUSTRIES INC（NC）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是NACCO INDUSTRIES INC的1.1倍（$75.5M vs $66.8M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -5.2%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 11.9%）
纳科工业是一家总部位于美国俄亥俄州克利夫兰的上市控股公司，核心业务聚焦采矿与自然资源领域，旗下划分煤炭开采、北美采矿、矿产管理三大业务板块。其中煤炭开采板块采用服务型商业模式，依据长期合约为发电企业及活性炭生产商运营露天煤矿。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
NC vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.1倍
$66.8M
营收增速更快
PBYI
高出32.9%
-5.2%
两年增速更快
PBYI
近两年复合增速
11.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $66.8M | $75.5M |
| 净利润 | $-3.8M | — |
| 毛利率 | 18.0% | 69.3% |
| 营业利润率 | 11.3% | 22.7% |
| 净利率 | -5.8% | — |
| 营收同比 | -5.2% | 27.7% |
| 净利润同比 | -150.8% | — |
| 每股收益（稀释后） | $-0.53 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NCPBYI
| Q4 25 | $66.8M | $75.5M | ||
| Q3 25 | $76.6M | $54.5M | ||
| Q2 25 | $68.2M | $52.4M | ||
| Q1 25 | $65.6M | $46.0M | ||
| Q4 24 | $70.4M | $59.1M | ||
| Q3 24 | $61.7M | $80.5M | ||
| Q2 24 | $52.3M | $47.1M | ||
| Q1 24 | $53.3M | $43.8M |
净利润NCPBYI
| Q4 25 | $-3.8M | — | ||
| Q3 25 | $13.3M | $8.8M | ||
| Q2 25 | $3.3M | $5.9M | ||
| Q1 25 | $4.9M | $3.0M | ||
| Q4 24 | $7.6M | — | ||
| Q3 24 | $15.6M | $20.3M | ||
| Q2 24 | $6.0M | $-4.5M | ||
| Q1 24 | $4.6M | $-4.8M |
毛利率NCPBYI
| Q4 25 | 18.0% | 69.3% | ||
| Q3 25 | 13.0% | 77.7% | ||
| Q2 25 | 10.0% | 76.5% | ||
| Q1 25 | 14.7% | 77.1% | ||
| Q4 24 | 12.0% | 76.4% | ||
| Q3 24 | 11.7% | 63.9% | ||
| Q2 24 | 13.4% | 77.4% | ||
| Q1 24 | 13.2% | 75.5% |
营业利润率NCPBYI
| Q4 25 | 11.3% | 22.7% | ||
| Q3 25 | 8.8% | 17.6% | ||
| Q2 25 | -0.1% | 12.7% | ||
| Q1 25 | 11.7% | 8.7% | ||
| Q4 24 | 5.5% | 22.6% | ||
| Q3 24 | 31.9% | 27.4% | ||
| Q2 24 | 14.1% | -4.6% | ||
| Q1 24 | 8.9% | -5.3% |
净利率NCPBYI
| Q4 25 | -5.8% | — | ||
| Q3 25 | 17.3% | 16.2% | ||
| Q2 25 | 4.8% | 11.2% | ||
| Q1 25 | 7.5% | 6.5% | ||
| Q4 24 | 10.7% | — | ||
| Q3 24 | 25.4% | 25.2% | ||
| Q2 24 | 11.4% | -9.6% | ||
| Q1 24 | 8.6% | -11.0% |
每股收益（稀释后）NCPBYI
| Q4 25 | $-0.53 | $0.26 | ||
| Q3 25 | $1.78 | $0.17 | ||
| Q2 25 | $0.44 | $0.12 | ||
| Q1 25 | $0.66 | $0.06 | ||
| Q4 24 | $0.99 | $0.40 | ||
| Q3 24 | $2.14 | $0.41 | ||
| Q2 24 | $0.81 | $-0.09 | ||
| Q1 24 | $0.61 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $49.7M | $97.5M |
| 总债务越低越好 | $100.8M | $22.7M |
| 股东权益账面价值 | $429.2M | $130.3M |
| 总资产 | $661.2M | $216.3M |
| 负债/权益比越低杠杆越低 | 0.23× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资NCPBYI
| Q4 25 | $49.7M | $97.5M | ||
| Q3 25 | $52.7M | $94.4M | ||
| Q2 25 | $49.4M | $96.0M | ||
| Q1 25 | $61.9M | $93.2M | ||
| Q4 24 | $72.8M | $101.0M | ||
| Q3 24 | $63.1M | $96.7M | ||
| Q2 24 | $62.4M | $96.8M | ||
| Q1 24 | $61.8M | $107.2M |
总债务NCPBYI
| Q4 25 | $100.8M | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | $99.4M | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | $29.0M | $90.7M | ||
| Q1 24 | $28.4M | $102.0M |
股东权益NCPBYI
| Q4 25 | $429.2M | $130.3M | ||
| Q3 25 | $426.4M | $115.3M | ||
| Q2 25 | $413.1M | $104.7M | ||
| Q1 25 | $409.1M | $97.1M | ||
| Q4 24 | $404.9M | $92.1M | ||
| Q3 24 | $397.3M | $71.1M | ||
| Q2 24 | $384.1M | $48.5M | ||
| Q1 24 | $381.6M | $51.0M |
总资产NCPBYI
| Q4 25 | $661.2M | $216.3M | ||
| Q3 25 | $637.6M | $202.9M | ||
| Q2 25 | $631.3M | $194.9M | ||
| Q1 25 | $634.2M | $196.2M | ||
| Q4 24 | $631.7M | $213.3M | ||
| Q3 24 | $597.4M | $220.7M | ||
| Q2 24 | $560.1M | $205.0M | ||
| Q1 24 | $538.0M | $214.1M |
负债/权益比NCPBYI
| Q4 25 | 0.23× | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | 0.25× | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | 0.08× | 1.87× | ||
| Q1 24 | 0.07× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $11.4M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流NCPBYI
| Q4 25 | $11.4M | $14.4M | ||
| Q3 25 | $42.3M | $9.7M | ||
| Q2 25 | $-7.8M | $14.1M | ||
| Q1 25 | $5.0M | $3.6M | ||
| Q4 24 | $25.2M | $15.6M | ||
| Q3 24 | $2.8M | $11.0M | ||
| Q2 24 | $4.1M | $1.0M | ||
| Q1 24 | $-9.8M | $11.2M |
自由现金流NCPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
自由现金流率NCPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
资本支出强度NCPBYI
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率NCPBYI
| Q4 25 | — | — | ||
| Q3 25 | 3.19× | 1.10× | ||
| Q2 25 | -2.39× | 2.41× | ||
| Q1 25 | 1.03× | 1.21× | ||
| Q4 24 | 3.33× | — | ||
| Q3 24 | 0.18× | 0.54× | ||
| Q2 24 | 0.68× | — | ||
| Q1 24 | -2.14× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NC
| Transferred Over Time | $42.7M | 64% |
| Transferred At Point In Time | $24.1M | 36% |
PBYI
暂无分部数据
